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Abstract
Acinetobacter baumannii is a pathogen rising in notoriety worldwide due to
outbreaks linked to multi-drug resistant strains. Research is currently focused on
identifying virulence factors, which may contribute to increased ability to cause human
disease, such as hemolytic activity and surface motility. The aim of this study was to
determine the presence of these two virulent traits in clinical isolates. Forty-eight
clinical isolates were recovered from University of Kentucky hospital in Lexington, KY.
No hemolytic activity was observed for any of the isolates. Evidence of surface motility
was observed in 13 isolates. The brand and concentration of media used allowed for
better observation of motility. There is potentially a multifactorial component to
virulence not examined in this study, which contribute to increased ability of A.
baumannii to cause disease. Preliminary statistical tests did not indicate a relationship
between surface motility and multi-drug resistance or being part of a complex of A.

calcoaceticus-A. baumannii. The lack of results indicates a need for further research to be
performed on A. baumannii to further classify virulence factors and examine the potential for a
multifactorial component resulting in its virulence.
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CHAPTER 1
LITERATURE REVIEW
The history of the Acinetobacter genus dates back to 1911 with the isolation of
the first strains of an organism named Micrococcus calcoaceticus by researcher M.W.
Beijerinck (24). This organism was named because it appeared as small spherical balls in
the calcium acetate-containing medium (24). Several species similar to this organism
were described throughout the next 40 years, but were associated with more than 15
different genera (12, 17, 24). Throughout the years the different genera and species
classifications included Diplococcus mucosus, Alcaligenes haemolysans, Achromobacter
anitatus, and Achromobacter musosus (24). In 1954, a proposal was made to separate
the motile from the nonmotile microorganisms within the genus Achromobacter (24). A
1968 paper published by Baumann et al. concluded that several of these species
belonged to a single genus and proposed the name of Acinetobacter meaning “unable to
move” (9, 24). At the time it was concluded further sub-classification based on
phenotypic characteristics was not possible (24). The scientific community did not
readily accept this new genus as demonstrated by the three year gap between
description and official recognition. Official acknowledgement of Acinetobacter was
made by the Subcommittee on the Taxonomy of Moraxella and Allied Bacteria in 1971
and recognized only a single species (18). This species was initially named A.
calcoaceticus and included organisms previously referred to by the epithet “anitratum”
and ”lwoffi” (18).
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The use of DNA-DNA hybridization by Bovet and Grimont in 1986 led to the
description of an additional 12 distinct species of Acinetobacter (24). Other significant
taxonomic modifications have been made over the last 27 years, describing additional
species (21, 24). Different methods have been used to describe species, leading to
conflicting reports regarding the number of species within the Acinetobacter genus.
Different sources have listed the number of species in the genus as being 23 (17), 25
(12), 27 (21), 31 (24), or 32 (14, 28). Anton Peleg, a researcher who has published
several different papers on Acinetobacter and A. baumannii, cites 27 validly named
species within the genus and 9 DNA-DNA hybridization groups (25). As of 2008, only 17
of these species had been officially named (28). These species include, but are not
limited to: A. pittii, A. nosocomialis, A. lwoffii, A. junii, A. haemolyticus, A. calcoaceticus,
and A. baumannii (25).
In general, the free-living saprophytes of the Acinetobacter genus are
considered to be ubiquitous pathogens in nature (12, 24, 28). Acinetobacter johnsonii,
A. lwoffii, and A. radioresistens can be found as part of the normal human and animal
skin flora, as well as in some spoiled foods (21). The widespread nature of the genus
falsely suggests that the species baumannii is ubiquitous in nature (21). While A.
baumannii has been isolated from soil, vegetables, and surface water through
enrichment, reports of isolation should be carefully considered to ensure identification
to the species level uses current validated methods that are more robust and accurate
(21, 24). Some strains of the bacteria have also been isolated from small-size living
organisms such as ticks, body lice, human body louse, and fleas (2, 28).
2

Very few species of the Acinetobacter genus are known to consistently cause
clinical disease. A. baumannii, A. nosocomialis and A. pittii are the only species
identified as being clinically relevant in the last few years (25). Many members of the
genus are known to comprise a part of the normal human skin flora (24, 25). Rates of
skin colonization by the different species of the genus have been reported to differing
degrees. These differences can be attributed to different research methods, as well as
differences in the methods used to identify the bacteria. Results with colonization rates
on the low end of the spectrum are thought to be the result of noise (25).
Phenotypic laboratory tests can lead to misclassification and misidentification
of Acinetobacter baumannii. There is difficulty in identifying, without question,
genetically closely related species no matter the genus (28). Misidentification of A.
baumannii as gram-positive occurs due to difficulty in the destaining process (24). This
would lead to the incorrect conclusion that the isolate belongs to a different species of
bacteria (24). It is very difficult to separate A. baumannii from A. calcoaceticus, A. pitti
(formerly known as genomic species 3), and A. nosocomialis (formerly known as species
13tu) using phenotypic laboratory tests (25, 28). When these species cannot be
separated they are referred to as the A. calcoaceticus-A. baumannii complex (12, 24,
25,28). Significantly less information is available regarding the non-baumannii species
compared to the baumannii species, adding to the difficulty of the separating process
(25). There is also a lack of identifiable traits that may cause one species of the genus to
be more equipped to cause human outbreaks (21, 25). Some epidemiologists have
concluded there is an overestimation of the prevalence of medical issues related to the
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bacteria due to the difficulty in identification and separation from the complex (17). The
clinical significance of Acinetobacter baumannii has also been called into question, in
part due to the difficulty in determining if clinically isolated cultures are the result of
skin colonization or from an infection (17).
The genome of Acinetobacter baumannii ranges from 3.2 Mb to 3.9 Mb
depending upon the particular isolate analyzed (1, 11, 28). Despite its small-sized core
genome, A. baumannii should be taken as a serious clinical threat due to its large
accessory genome containing numerous antibiotic resistance genes. Horizontal gene
transfer can be utilized by the bacterium to acquire new genetic material through
plasmids, integrons, and transposons (6). Plasmids have been associated with the
transfer of antibiotic resistance genes more than transposons and integrons within the
Acinetobacter genus (20). The bacterium also has the capability of rearranging existing
genes allowing for evolution of virulence factors such as resistance to antibiotics. A
retrospective study performed in the UK found a rise in carbapenem resistance from
0%, in 1998, to 55%, in 2006, in A. baumannii species causing bacteremia (31). Crude
mortality rates for bloodstream infections resulting from A. baumannii have been
estimated to range between 28 and 43 percent (21). A. baumannii has been described
as an organism threatening the current antibiotic era due to existence of pandrugresistant strains (24).
While researchers acknowledge a lack of information regarding virulence
factors, some have been identified and need to be described further. These factors
include, but are not limited to: siderophore-mediated iron acquisition systems, biofilm
4

formation, capsule formation, quorum-sensing, surface proteins, and expression of
genes regarding acquisition of essential nutrients (21, 25). Desiccation, hemolytic
activity, and surface motility have also been identified as potential virulence factors (2).
Some of these virulence factors, such as surface motility, have a lot of conflicting
research regarding their properties.
The pathogenesis of Acinetobacter baumannii has been linked to its ability to
evade the bactericidal activity of host serum. In particular, one study found the
mortality of patients correlated with the serum resistance of A. baumannii (32). The
ability to resist the bactericidal activity of serum was linked to acquisition of a surface
protein named factor H (32). The study acknowledged other research that found factor
H did not bind to the surface of the bacteria (32). The conflicting information regarding
whether or not factor H binds to the surface of the bacteria could be the result of the
different strains of the bacteria used for each study or it could be the result of other
unknown factors such as differing laboratory conditions. A phospholipase D and
transposon mutant in a gene for penicillin binding protein 7/8 have also been linked to
reduced serum resistance (2).
A number of hemolysin-related genes and two phospholipase C (plc) genes
have also been found in all of the strains sequenced, despite A. baumannii historically
being classified as non-hemolytic (2, 28). This classification may be linked to the type of
blood used as well as the assay method performed. Hemolysis has never been observed
on sheep blood agar, but some evidence of hemolysis on horse blood agar exists (2, 24).
Liquid assays have shown to be more sensitive at showing the hemolytic activity (2).
5

Even though the sensitivity is higher using liquid assays the hemolytic activity is
significantly lower than that observed in species of bacteria known to be hemolytic.
Despite A. baumannii being historically described as being non-motile,
researchers have also examined the role of motility in the pathogenesis of the
bacterium due to the presence of several genes related to motility (8). Genomic analysis
has revealed a lack of flagellar genes (27). Type IV pilus apparatus and pilus assembly
genes have been identified within the A. baumannii genome. Type IV pilus assembly
protein genes identified within the A. baumannii genome are pilQ, pilO, pilN, pilW, and
pilM (2, 25, 27). Type IV pilus biogenesis protein genes pilB and pilJ have also been
identified (2, 25). Fimbrial biogenesis genes fimT, pilB, and pilZ have also been found
within the genome of A. baumannii (2, 25, 27). pilU, pilI, and pilT genes, which are
responsible for pilus retraction through twitching motility, have also been identified
within the genome (25, 27). The A. baumannii strain M2, lacking a functional pilT gene,
was found to have a 54% reduction in motility compared to strains with a functional
gene (27). Twitching motility represents a significant component in overall motility (27).
A single conclusion regarding the motility, or lack thereof, has not been drawn
due to conflicting results. Differences in laboratory conditions can play a part in not
allowing for observation of motility in all clinical isolates studied (8, 22). Studies have
shown that most movement tends to occur on the surface of semi-solid media and
decreases as the concentrations of agar increase (8, 22). A study of the M2 strain of A.
baumannii found robust surface motility on Luria-Bertani (LB) broth modified with 10 g
tryptone, 5 g yeast extract, and 5 g NaCl with 0.2-0.4% concentration agar plates, while
6

higher concentrations of agar showed less evidence of motility (8). Similar to results
observed in other bacteria, differences in evidence of surface motility have been
observed depending on the brand of media used (8). When the test was performed
using the modified LB broth base described above with Difco agar media inhibition was
observed at 0.35%, while inhibition of motility was observed at 0.5% when Eiken agar
was used (8). Inhibition of motility occurs at higher concentrations of agar because the
media is harder than at lower concentrations. Eiken agar is thought to have compounds
that promote motility of bacteria and/or increase the “wettability” allowing the bacteria
cells to spread easier (8). Specific compounds in EIken agar, which promote spreading
of the bacteria, have not been identified.
The patterns of motility observed have been shown to differ within and
between different strains (8, 22). Branching patterns of motility have been observed in
the M2 strain of A. baumannii using Difco media with a modified LB broth base (8).
Evenly distributed patterns of migration from the point of inoculation have been
observed in the M2 strain using Eiken media with a modified LB broth base (8). Other
strains tested in the same study found varying patterns of motility ranging from simple
concentric rings to complex flower-like patterns as well as a few strains with no signs of
motility as shown below in Figure 1 (8). A translucent zone observed just ahead of the
advancing colony was thought to be a secreted surfactant (8¸ 33). Further studies are
needed to determine if motility differs by using different mechanisms, if the capacity of
the organism to sense environmental cues differs, or if other factors are in play.
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Figure 1: Motility on agar plates adapted from Source: Clemmer, K.M. R.A. Bonomo &
P.N. Rather. 2011. Genetic analysis of surface motility in Acinetobacter baumannii.
Microbiology 157: 2534–2544.
Motility on Difco Bacto agar (a) and Eiken agar (b) at the percentages indicated.
Branching pattern of motility shown on (a) and concentric rings of motility on (b).
A. baumannii has also been studied to determine how well it can resist drying
out or dessication. Desiccation has been studied because it has potential to be a major
contributing factor to the persistence of A. baumannii in hospital environments. The
survival times of A. baumnnii are significantly longer than other species within the
Acinetobacter genus and are comparable to those of Staphylococcus aureus (2). A study
by Jawad et al. found the mean survival time of 22 studied strains to be 27.29 days by
looking at well-defined hospital-outbreak related strains and sporadic isolates from
hospitalized patients in the same geographic area (16). Another study by Giannouli et
al. looked at several different distinct genotypes of international clonal lineages I-III and
found survival times ranged from 16 to 96 days (13). Strains belonging to genotypes
ST1, ST78, and ST25, all part of international clonal lineage I, were found to have higher
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survival times ranging from 75 to 89 days (13). A typical reference strain, ATCC 19606,
has been shown to resist desiccation for less than 29 days in the Giannouli et al. (13)
study and 6 days in the Jawad et al. (16). The differences in survival times can be
attributed to different strategies used by the strains, differences in research protocol,
unknown factors, or a combination of the above. Desiccation is another example of the
lack of information known about A. baumannii. Further research is needed to better
describe and determine virulence factors such as desiccation.
International clonal lineages have been studied to determine if differences
exist in the virulence factors between the strains. Each international clonal lineage has
a central, predominant genotype with a very few single locus variants (30). It has been
found these international epidemic clonal lineages have selective advantage for causing
disease over non-epidemic strains, although the reasons are still unknown (30). One
particular study of international clonal lineages found regional differences in regards to
aminoglycoside-resistance genes. Strains from the Czech Republic were determined to
have a limited number of resistant genes and integron structures when compared to
strains from other European countries (23). Differences in antibiotic usage and local
availability of resistance genes, to acquire through lateral gene transfer, were
considered factors for these differences (23). International clonal lineages I and II from
the Czech Republic were found to share all resistance genes except one as well as
integron regions (23). The lack of differences of aminoglycoside-resistance genes in the
two clonal lineages examined indicate the possibility that strains occupying one
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geographical region may share gene pools more readily through horizontal gene transfer
than strains in differing geographical regions (23).
The ability for bacteria to acquire iron from their environment is essential to
growth and inability to acquire iron in iron-poor environments leads to death (2). Hosts
can defend themselves against potential bacterial infections by reducing the amount of
free extracellular iron concentrations. One reason Acinetobacter baumannii has been
able to infect numerous patients is due to the different strategies developed to collect
iron from the environment. Several different mechanisms for iron-uptake have been
observed and examined through studies of A. baumannii strains living in different
environments. Direct contact between the bacteria and hemoglobin, such as in the gut
of a host, allow the bacteria to aggregate and destroy the cells releasing the iron into
the environment. This allows for quick uptake of the iron as exhibited in the SDF strain
isolated from a human body louse (2, 28). Other systems involve the use of high affinity
molecules released outside of the cells to collect the iron. A. baumannii strains AYE and
ATCC 19606 use the acinetobactin sideophore to chelate iron by competing with host
iron-binding proteins (28, 33). A genetic analysis of ATCC strain 17978 revealed two
independent siderophore-mediated iron acquisition systems acquired through
horizontal gene transfer and transposition (33).
Despite the official genus name of Acinetobacter being relatively new, the
history of the genus dates back to organisms originally classified as belonging to other
genera. A particular species of the genus, A. baumannii, has been known to cause
human disease throughout the world. Despite some conflict regarding the extent of
10

clinical significance researchers agree more information regarding the species is needed
as it is a valid clinical concern. One focus of research regarding this particular species is
the examination of virulence factors potentially responsible for increases in human
disease. Motility, hemolytic activity, desiccation, and ability to acquire iron from the
environment are among the virulence factors studied. Thus far, there is conflicting
research regarding the significance of each potential virulence factor and further
research is needed to further describe each factor.
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CHAPTER 2
INTRODUCTION
The 23 species found in the Acinetobacter genus include environmental
organisms, all of which can be human pathogens although most are not associated with
human disease. The most prevalent and worrisome clinical species worldwide is
Acinetobacter baumannii, which has been identified as the source of multiple outbreaks
and is emerging globally as a troublesome pathogen (14, 24). According to the CDC,
approximately 80% of infections caused by the Acinetobacter genus are specific to the
baumannii species (7). Strains of A. baumannii are isolated in up to 1% of nosocomial
infections (28). A. baumannii, a gram-negative, glucose non-fermentative, non-motile,
non-hemolytic, catalase-positive, oxidase-negative aerobic coccobacillus, is frequently
found as an opportunistic pathogen in patients with mechanical ventilation, urinary or
respiratory catheters (5, 12, 14, 16, 17, 24). Critically-ill patients and patients with
openings in their skin and respiratory tract are those most often afflicted by A.
baumannii (24).
The majority of infections are hospital-acquired or nosocomial infections.
Researchers have seen a rise in infections in long-term care facilities, such as nursing
homes, and in wounded military personnel (21). Infection with A. baumannii can occur
through contact with contaminated hospital personnel or by exposure to contaminated
hospital equipment (21, 29). Evidence has shown the bacterium can colonize implanted
removable devices, such as catheters, arterial pressure monitoring devices, and
12

respiratory equipment (16, 21). Dry environmental objects, such as mattresses, pillows,
and remotes, have also been implicated as a method of transmission (16).
While mortality rates are largely unknown, evidence supports prolonged
hospital stays in ICUs leading to poorer outcomes in afflicted patients and increased
attributable mortality (19, 21). Hospital-acquired pneumonia is the most commonly
observed clinical presentation (14, 21). Bloodstream infections, urinary tract infections,
hospital-acquired meningitis, wound infections, and bone infections are also clinical
syndromes due to infections with A. baumannii (14, 16, 21). Intensive care units
experience outbreaks which are difficult to control and quick to spread; the source of
infections may be difficult to identify in these outbreaks (14).
In the past, A. baumannii was considered to be a pathogen of low virulence,
meaning it was thought to have a lowered ability to infect and cause disease (14). In the
past, most studies involving A. baumannii were based on describing the outbreaks,
source of outbreaks, risk factors, and outcomes to help improve therapeutic treatment
(21). Several epidemiological studies have shown the bacteria can survive in harsh
hospital environments as well as cause disease outbreaks. Recognition that limited
knowledge exists regarding the organism’s pathogenicity and virulence factors have
caused many researchers to question the status quo. Virulence factors have been
recently identified for A. baumannii, although relatively few were identified (2, 24).
Limited data has been collected concerning their function to date (2, 24). These factors
include, but are not limited to, resistance to desiccation, the ability to evade the
bactericidal activity of blood serum, resistance to iron starvation, biofilm formation, and
13

motility (2, 32). In addition to phenotypic virulence factors, genes which influence ironuptake, biofilm formation, and quorum sensing have been found to differ between
species in the Acinetobacter genus (14, 28).
Previously isolated strains of Acinetobacter baumannii have shown differences
in their ability to lyse blood cells as well as differences in motility (2). Resistant
(outbreak related) and antibiotic susceptible (non-outbreak related) isolates have been
shown to exhibit limited hemolytic activity in liquid medium using defibrinated horse
blood, but not using defibrinated sheep blood (2). Surface motility levels have been
shown to differ between multi-drug resistant and antibiotic susceptible isolates (2, 21).
Differences in motility have also been seen within clinical isolates as not all strains have
displayed motility under laboratory conditions (21).
PURPOSE OF RESEARCH
The objective of this study was to identify the virulence factors present in
clinical isolates of Acinetobacter baumannii collected from the University of Kentucky
Hospital in Lexington, KY. The virulence factors to be assessed in this study included
hemolytic activity (using two different methods) and surface motility. The ability of A.
baumannii to persist in hospital environments, as well as to develop multi-drug
resistance, increases the likelihood of the species becoming endemic in local hospitals.
Identifying the characteristics of A. baumannii isolates will allow hospital staff to make
informed decisions about patients who have risk factors for A. baumannii infection.
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CHAPTER 3
MATERIALS AND METHODS
COLLECTION AND STORAGE OF ISOLATES
Isolate ATCC 19606 was ordered from Microbiologics to act as a control. The
clinical isolates for this study were obtained from the University of Kentucky Medical
Center. A total of 50 isolates were collected from the medical center and mailed
overnight on TSA slants; only 48 isolates were recovered. Sixteen of the isolates
obtained were previously determined to be multi-drug resistant. Nine isolates were
determined to be a complex of A. calcoaceticus-A. baumannii . Four isolates were a
complex of A. calcoaceticus-A. baumannii and multi-drug resistant. More information
about the isolates can be found in Appendix A, Table 2: Characteristics of bacterial
strains used in this study. On the day the isolates arrived, they were transferred from
the TSA slants onto Luria-Broth (LB) plates and incubated for 24 hours at 35°C. All
isolates were harvested and then stored in a -80°C freezer in one milliliter of 10%
serum-sorbitol solution. Prior to each test, the isolates were cultured onto LB plates
using isolation streaks and incubated for 24 hours at 35°C. Each procedure was
performed three different times.
HEMOLYTIC ACTIVITY
Hemolytic activity of the isolates was determined using both an agar plate
method and a liquid hemolytic assay. Activity for the plate assay was determined by
incubating 5 μL of bacteria-containing saline, normalized to an OD600 = 1.00 ± 0.1, on
15

Columbia agar with 5% defibrinated horse blood for 18 hours at 35°C. Zones of
clearance were used to determine whether hemolytic activity was present or not.
Staphylococcus aureus was used as a control to indicate a positive reading. Bouvet et al.
determined A. baumannii ATCC 19606 to be non-hemolytic and thus this isolate was
used a negative control (4).
The liquid hemolytic activity assay was performed by incubating one colony of
the isolate, grown on a LB plate as described above, for 3 hours at 37°C with gentle
agitation in Tryptic-Soy broth (TSB) with 1% defibrinated horse blood. Prior to the horse
blood being added to the TSB the blood cells were washed with phosphate buffer
solution (PBS) and centrifuged for 10 minutes at 1000 g and 4°C. Excess liquid was
removed and discarded. The process of washing the horse blood was performed three
separate times. After incubation, the TSB containing bacteria mixture was centrifuged
for 20 minutes at 1000 g and 4°C. The supernatant was removed and the OD600 was
determined. Prior to each OD600 reading, the spectrometer was set to zero using sterile
distilled water. The percentage (P) of blood lysis was determined using the Antunes
equation P = (X-B)/(T-B)X100 by subtracting the OD600 of sterile distilled water (B) from
the value of the supernatant (X) and dividing by the difference of the OD600 of distilled
water (B) and TSB with horse blood(T) (2).
SURFACE MOTILITY
Surface motility was determined by stab inoculating petri dishes containing
surface motility agar with 1% TTC. Sterile saline containing bacteria was normalized to
OD600 = 1.00 ± 0.1 prior to stab inoculation. Plates were incubated at 35°C for 18 hours.
16

Motility was determined to be positive or negative based on the amount of red
indication from the TTC.
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CHAPTER 4
RESULTS
HEMOLYTIC PLATE ASSAY
There were no zones of clearance indicating hemolytic activity for any of the
48 isolates tested. This hemolytic test was also performed on a negative control (ATCC
19606) and positive control (Staphylococcus aureus). Figure 2 shows a representative
sample indicating a lack of hemolytic activity and the positive control indicating the
presence of hemolytic activity.

(a)

(b)

Figure 2: Hemolytic-negative and hemolytic-positive representative plates.
(a): A representiave sample of Acinetobacter baumannii including the negative control,
ATCC 19606. This plate shows no zones of clearance indicating a lack of presence of
hemolytic activity.
(b): Staphylococcus aureus was used as a positive control of hemolytic acitivy. Note the
zones of clearance indicated by the lighter circles surrounding the darker circles.
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HEMOLYTIC LIQUID ASSAY
The average OD600 of the isolates ranged between 0.018 and 0.136.
Percentage of blood cells lysed differed from 2% to 12%. The negative control, ATCC
19606, had an average OD600 of 0.052 while the positive control, S. aureus, had an
average OD600 of 0.606. The negative control had an average of 6.501% of blood cells
lysed, while the negative control had an average of 75.320% of blood cells lysed.
Differences in the average percentage of blood cells lysed by isolate are illustrated in
Figure 3 and Figure 4. Differences in the average OD600 by isolate are illustrated in
Figure 5 and Figure 6.

Average Percentage of Blood Cells Lysed by
Clinical Isolates of Acinetobacter baumannii
Percent of blood cells lysed
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Figure 3: Average Percentage of Blood Cells Lysed in Supernatant without a Positive
Control.
This graph shows the average percentage of three assays for each isolate of blood cells
lysed. The Positive Control is not represented in this figure to show how the isolates
compared to each other.
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Average Percentage of Blood Cells Lysed by
Clinical Isolates of Acinetobacter baumannii
and Positive Control Species Staphylococcus
aureus
90
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Figure 4: Average Percentage of Blood Cells Lysed in Supernatant with a Positive
Control Species Staphylococcus aureus.
This graph shows the average percentage of three assays for each isolate of blood cells
lysed including the Positive Control species Staphylococcus aureus, located on the far
right of the graph. This graph is intended to show how the percentage of blood cells
lysed by Acinetobacter baumannii compared to the Positive Control.
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Average OD600 of Blood Cells Lysed by Clinical
Isolates of Acinetobacter baumannii
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Figure 5: Average OD600 of Supernatant without a Positive Control.
This graph shows the average OD600 of three assays for each isolate without a Positive
Control. This graph is intended to show how the average OD600 compared to the other
isolates.
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Figure 6: Average OD600 of Supernatant including a Positive Control Species
Staphylococcus aureus.
This graph shows the average OD600 of three assays for each isolate, including a Positive
Control, Staphylococcus aureus. This graph is intended to show how the average OD600
of each isolate compared to the Positive Control species Staphylococcus aureus.
SURFACE MOTILITY
Of the 48 clinical isolates and one reference strain (ATCC 19606) tested, only
13 clinical isolates had evidence of surface motility. 36 clinical isolates and reference
strain ATCC 19606 did not show motility. Figure 7 shows a representative sample
determined to be positive for surface motility and a representative sample determined
to be negative for surface motility. Table 1 shows the motility results for all strains
tested. Figure 8 and Figure 9 show the differences in count of isolates by motility and
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multi-drug resistance and complex of A. calcoaceticus-A. baumannii. Figure 10 and
Figure 11 are statistical results showing the relationship between motility and multidrug resistance and complex of A. calcoaceticus-A. baumannii.

(a)

(b)

Figure 7: Surface motility-negative and surface motility-positive representative plates.
(a): This plate shows a representative sample, isolate 35, which was determined to have
surface motility. The bright red spots are from an indicator, TTC, included in the
preparation of the surface motility agar. The bright red spots indicate surface motility.
Note the spots are larger than the plate on the right indicating no surface motility.
(b): This plate shows a representative sample, isolate 9, which was determined to have
no surface motility. Note the lack of bright red spots and smaller diameter of the dull
red spots when compared to the plate on the left.
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Multi-drug Resistant vs. Surface Motility
Not MDR
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MDR
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5
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Figure 8: Graph of Multi-drug resistant vs Surface Motility.
This graph shows the count of isolates determined to be positive and negative for
surface motility categorized by determination of multi-drug resistance. Note the lack of
difference of count for each surface motility characterization within each MDR
categorization.

Complex and Surface Motility
Not a complex
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Complex of A. calcoaceticus-A. baumannii
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Figure 9: Graph of Complex vs. Surface Motility.
This graph shows the count of isolates determined to be positive and negative for
surface motility categorized by determination of whether the isolate was a complex of
A. calcoaceticus-A. baumannii or not. Note the lack of difference of count for each
surface motility characterization within each complex categorization.
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Statistical Tests for Multi-drug resistant vs. Surface Motility
Chi-Square
Phi Coefficient

Test Value p-value
1.931a
0.381
0.195

0.381

a. 2 cells (33.3%) have expected count less than 5. The minimum expect
count is .78.
Figure 10: Statistical Tests for Multi-drug resistant vs. Surface Motility.
This chart shows the statistical test values for the Chi-Square and Phi Coefficient tests
performed to determine if a relationship exists for isolates classified as Multi-drug
resistant and whether or not they have surface motility. Note the much higher test
value when compared to the p-value for the Chi-Square test. Note the much lower test
value when compared to the p-value for the Phi Coefficient test.

Statistical Tests for Isolates that are part of a complex vs. Surface Motility
Chi-Square
Phi Coefficient

Test Value p-value
1.870b
0.393
0.191

0.393

b. 3 cells (50.0%) have expected count less than 5. The minimum expected
count is .51.
Figure 11: Statistical Tests for Complex vs. Surface Motility.
This chart shows the statistical test values for the Chi-Square and Phi Coefficient tests
performed to determine if a relationship exists for isolates classified as being part of an A.
calcoaceticus-A. baumannii complex and whether or not they have surface motility. Note the
much higher test value when compared to the p-value for the Chi-Square test. Note the much
lower test value when compared to the p-value for the Phi Coefficient test.

25

Table 1: Surface Motility results for all A. baumannii isolates tested broken down by multidrug resistance and if the isolate was determined to be A. calcoaceticus-A. baumannii
complex
Strain
Part of a Complex?
Multi-drug Resistant Motility
1

-

+

+

2

-

-

+

4

-

-

+

5

-

-

-

6

-

-

-

7

-

-

-

8

-

-

-

9

-

-

-

10

+

-

-

11

+

-

-

12

-

+

-

13

-

+

-

14

-

+

-

15

-

+

-

16

+

-

-

18

-

-

-

19

-

-

-

20

-

+

-

21

-

-

+

22

-

-

+

23

-

+

+

24

-

-

-

25

-

-

+

26

-

+

+
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Table 1: (continued)
Strain
27

Part of a Complex?
-

Multi-drug Resistant
+

Motility
-

28

-

-

+

29

-

+

-

30

-

+

-

31

+

+

-

32

+

-

-

33

+

+

-

34

+

-

-

35

-

-

+

36

-

+

-

37

+

-

-

38

-

-

-

39

-

-

-

40

+

+

-

41

+

-

-

42

+

-

-

43

+

+

-

44

-

+

-

45

-

-

-

46

-

-

-

47

+

-

+

48

+

-

+

49

-

-

+

50

-

-

-

ATCC 19606

-

-

-
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CHAPTER 5
DISCUSSION
Acinetobacter baumannii has emerged as a worldwide pathogen of concern
due to the increasing number of outbreaks of disease associated with the bacteria and
the arise of multi-drug resistant strains of the bacteria (2, 24). Many different studies
attempting to identify, classify, and describe virulence factors have stemmed from this
concern. In an attempt to further our understanding of the role of surface motility and
hemolytic virulence factors, isolates were acquired for study from the University of
Kentucky hospital in Lexington, KY. A total of 50 isolates were collected from different
areas of the hospital over a period of 6 months. Only 48 of those isolates were
recovered for testing. Reference strain ATCC 19606 was also purchased as a control
organism.
In order to determine hemolytic activity two different assay methods were
used; one was qualitative while the other was quantitative. Defibrinated horse blood
was chosen for both assays as studies have shown hemolysis can be observed on horse
blood agar, but not sheep blood agar. The qualitative method involved plating the
bacteria onto a blood agar plate and observing the zone of clearance or lack thereof.
The qualitative method involved growing the bacteria in a suspension of tryptic soy
broth and using the optical density to determine the amount of blood cells lysed. No
zones of clearance were observed for any of the clinical isolates for the qualitative
method; see Figure 2 to view representative plates of positive and negative hemolytic
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results. The lack of hemolytic activity on plates is consistent with the species historically
being described as non-hemolytic (2). The quantitative liquid assay showed limited
signs of hemolytic activity averaging approximately 6% of blood cells lysed. A strain of
Staphylococcus aureus was used as a positive control and lysed approximately 75% of
the blood cells.
Figure 3 shows the percentage of blood cells lysed by the clinical isolates and
the reference strain ATCC 19606. In this figure it appears there is a significant difference
in the percent of blood cells lysed; however Figure 4 shows the clinical strains as
compared to the positive control. In this figure it is easy to see there is a significant
difference between the percent of blood cells lysed by the A. baumannii isolates and the
positive control, but not within the clinical isolates and reference strain. The significant
difference in percentage of blood lysed compared to the positive control led to the
conclusion that there was no hemolytic activity for the clinical isolates or the reference
strain. Using a limited number of isolates (4), Antunes et al also observed limited
hemolytic activity using a liquid assay with an average of approximately 12% of blood
cells lysed for all clinical isolates (2). Compared to the Antunes study, this study tested
more isolates, 48 isolates versus 4, accounting for the difference, 6% vs. 12%, of average
blood cells lysed by all isolates.
Staphylococcus aureus is a gram-positive bacterium known to have hemolytic
activity. S. aureus damages blood cells by releasing alpha-hemolysins which bind to the
surface membrane of host blood cells causing the release of eicosanoids and cytokines
and resulting in an inflammatory response (26). Leukocytes and platelets are the most
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sensitive components of blood in humans to the alpha-hemolysins (26). Alphahemolysins are also responsible for osmotic phenomena, cell depolarization, and loss of
ATP (26). Mutants of S. aureus, which produce lowered levels of alpha-hemolysins were
created in the lab, have shown to have a lowered ability to cause infection in several
different animal models (26). Purified versions of the alpha-toxin have been used to
show an increased ability to cause infection in the same animal models (26). As a result
of alpha-hemolysins, hemolytic activity is shown to be an important virulence factor for
S. aureus.
A gram-negative bacterial species identified as lacking hemolytic activity is
Klebsiella pneumoniae. Similar to A. baumannii, it is an opportunistic pathogen known
to infect patients with an underlying disease. It is ranked second to Escherichia coli as a
cause of nosocomial gram-negative bacteremia (26). A disadvantage to lacking the
ability to lyse blood cells is that the bacteria must develop other methods to cause
disease in a host. Capsular antigens, pili, serum resistance, lipopolysaccharide, and
siderophores have been identified as virulence factors for Klebsiella pneumoniae (3).
The capsular antigens create a thick surface surrounding the cell membrane, making
phagocytosis by host cells extremely difficult (3). Pili, sometimes referred to as fimbriae,
are used to attach the bacteria to the human mucosal surfaces making the first step of
infection possible. Siderophores are iron chelators, which compete with host factors for
iron, allowing more iron to be available for use by the bacterial cell.
Some of these virulence factors can be neutralized easier than others. Studies
have shown cranberry juice is effective at preventing adhesion for enterobacteria in the
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gastrointestinal tract (3, 26). The prevention of adhesion has been successful in
preventing infection and in the eradication of existing infection in colonized patients.
Adhesion is the first step of infection, thus when the bacterial cells cannot adhere to the
human host cells then infection does not occur. It would be a greater advantage for
bacteria, such as Acinetobacter baumannii, to have the ability to lyse blood cells than to
have higher adhesive ability because the effects of hemolysis cannot be overcome as
easy. As demonstrated by Staphylococcus aureus, hemolysis elicits an inflammatory
reaction resulting in the death of the invading bacteria in a healthy human host. The
inflammatory reaction can cause a cascade of effects that lasts after the bacteria is
eradicated, resulting in more damage than is caused by adhesion.
Another potential virulence factor assessed was surface motility. Thirteen of
48 isolates assessed did show evidence of surface motility (Table 1). The concentric rings
of motility observed in this study were similar to those observed on Eiken agar by
Clemmer et al (see Figure 1 versus Figure 7). The other 35 strains and reference strain
ATCC 19606 did not show evidence of surface motility. Signs of motility were
unexpected because the name Acinetobacter derives from a greek word meaning nonmotile and the species is typically described as being non-motile (8). However, despite
the historical categorization of being non-motile, other researchers have shown it is very
difficult to observe surface motility in laboratory conditions accounting for the signs of
motility observed by this study. Surface motility has also been found to be highly
variable between several environmental and clinical isolates of A. baumannii from
different geographic regions (8). Clemmer et al. also found evidence that surface
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motility for the M2 strain differs based on the brand and concentration of agar (8).
Surface motility was best evidenced on Eiken agar with a concentration of 0.2-0.4% (8).
Concentrations above 0.4% allowed for less motility observed (8).
The observations of surface motility in this study are either evidence of actual
motility or false positives resulting from the methods used. Surface motility genes could
have been acquired by the A. baumannii strains through lateral gene transfer from other
bacteria found inside the hospital environment. Observation of motility in this study
could be attributed to the low concentration (0.2%) of agar. The low concentration of
agar and use of TTC indicator may have allowed for low levels of motility to be
observed. These levels may not prove statistically significant when compared to
bacterial species with known motility. Results were not collected to rule out this
possibility. Genetic testing for motility genes would provide more evidence for either of
these options, but were not included in the scope of this study.
The unexpected evidence of surface motility is most likely not linked to the
complex of A. calcoaceticus-A. baumannii (this will be referred to as a complex from this
point forward). Similar to A. baumannii, Acinetobacter calcoaceticus is not identified as
being motile historically. Nine of the 48 recovered isolates for this study were
determined to be part of a complex and only 2 of these isolates had evidence of surface
motility. The low ratio of complex isolates with evidence of surface motility versus the
complex isolates without evidence of surface motility does not indicate a relationship
between the two variables. The surface motility observed in this study is possibly the
result of acquisition of motility genes from foreign sources.
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Specific genes could be identified through whole genome sequencing although
this would be time consuming and costly. Whole genome sequencing would allow for
the identification of all genes related to a specific virulence factor. This would be
especially useful because a gene may be identified that researchers may not expect. It
would be more cost effective to use primers to look for specific genes using PCR if there
was evidence to support the presence of those genes. There are several different
molecular fingerprinting methods that can be used to study the genome of A.
baumannii, including f-AFLP (fluorescent amplified fragment length polymorphism),
RAPD (random amplified polymorphic DNA), PFGE (pulsed-field gel electrophoresis), and
REP-PCR (repetitive extragenic palindromic PCR). f-AFLPhas been identified as a way to
determine the genetic relatedness of strains with high discriminatory power (10). This
test can take 72 to 96 hours to perform. REP-PCR has been identified as a cost-effective
efficient method to determine the genetic relatedness of specific strains of A.
baumannii, requiring only 4 hours to perform (10). REP-PCR was also found to have high
discriminatory power and to be a reliable and reproducible method of identifying the
relationship of two particular isolates (10), REP-PCR fingerprint analysis can be
combined with the use of specialized software, VIGI@ct DiversiLab, to help automate
surveillance surveys to identify outbreaks quickly by comparing the fingerprints of
multiple isolates at once (10). f-AFLP needs additional software before automated
surveillance can occur (10).
Chi-square and phi coefficient statistical tests were performed to determine if
a relationship exists between multi-drug resistant strains and surface motility as well as
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strains consisting of a complex of A. calcoaceticus-A. baumannii and surface motility.
Due to the lack of observed hemolysis, these statistical tests were not conducted for the
hemolytic activity virulence assays. Similarly, there were no isolates where surface
motility was observed that were both multi-drug resistant and were determined to be a
complex. Therefore no statistical tests were performed to determine if there was a
possible relationship between multi-drug resistant, complex organisms with surface
motility. The chi-square test was used to determine if a relationship existed and the phi
coefficient determined the strength of the relationship.
The chi-square test result was not statistically significant indicating that no
relationship exists between surface motility and multi-drug resistance or being part of a
complex of A. calcoaceticus-A. baumannii (see Figure 10 and Figure 11). Similarly, the
phi coefficient test indicated an extremely poor strength of relationship. Figure 8 and
Figure 9 show the lack of differences of count of isolates testing positive and negative
for motility against multi-drug resistance and a complex. These tests should only be
considered as preliminary results due to the low sample size resulting in no statistical
power. In order for either test to have any statistical power there needs to be at least
five results for each combination of factors (+surface motility +MDR, +surface motility –
MDR, –surface motility +MDR, and –surface motility –MDR). There were only three
isolates positive for surface motility and multi-drug resistance. Only two isolates were
determined to be positive for surface motility and part of a complex. The probability of
type-II error, failure to reject the null hypothesis of no relationship existing, is very high
due to the low number of results. The lack of statistical significance does not mean no
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relationship exists between these factors; it can only be assumed a potential
relationship was not detected in this study. Despite the lack of significance for this
study, the idea that a relationship exists should not be disregarded. Further studies
should be performed to classify with greater statistical confidence if a relationship does
or does not exist.
Highly virulent isolates may not have been detected because this study did not
assay for all potential virulence factors. These additional factors have been shown to
play a part in virulence for other bacterial species. Iron-uptake is an example of
virulence factor that was not assessed. Given that iron is essential for bacterial growth
iron acquisition genes, which allow the bacteria to acquire iron in low-iron conditions,
would be a significant advantage. Another example would be desiccation. In hospital
environments, the ability to survive for long period of times without drying out would
allow bacteria on environmental objects to cause disease in more patients.
Another potential reason the results of this study did not find highly virulent
isolates is possibly because the multi-factorial aspect of virulence was not taken into
account. A multi-factorial approach to virulence means that several different factors all
play a role in the pathogenicity. Surface motility, hemolytic activity, increased
desiccation times, greater ability to obtain iron from the environment, increased
adhesion ability, etc. are not individually responsible for the fact that a particular strain
can cause disease more readily than another. The presence of several of these factors
account for the overall virulence of an isolate. Specific virulence factor assays may not
have statistically higher results when compared with other species known to possess the
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virulence factor. The combination of all the slight differences would allow the bacteria
to have more opportunities to cause disease. This study did not assess enough virulence
factors to be able to determine if there was a multi-factorial component of virulence for
these isolates. Future studies should consider the possibility that a combination of
virulence factors have a positive and statistically significant relationship with the ability
of the species to cause disease.
It is important to remember the small scope of this study means the results or
lack of results cannot be applied worldwide. Genetic differences have been described
between different A. baumannii strains from different epidemic lineages, such as
international clonal lineages I-III. The lack of genetic testing in this study is a hindrance
in relating the results with other studies due to the lack of information to classify the
lineage. For example, isolate data from appendix A shows isolates 21 and 22 were both
isolated from the axilla/groin area in the A07A area of the hospital. Genetic testing
would have been able to determine if these isolates are in fact the same strain of
bacteria or different. The lack of genetic testing also made it impossible to determine
the international clonal lineage relationship. This lack of information should be
considered when comparing these results to other studies with more thorough testing.
These results should only be considered accurate within the hospital. Even within the
hospital, these results should be interpreted with caution as the presence of virulent
traits can change through time.
Despite the lack of results from this study, Acinetobacter baumannii should be
considered as a legitimate threat to patient health in the University of Kentucky
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hospital. Lateral gene transfer is one method by which this bacterium can become more
harmful as time passes. The acquisition of multi-drug resistance is a prime example of
how the bacteria can become more harmful. Any acquisition of virulent traits allows for
a higher possibility of poorer patient outcomes from infection by this opportunistic
pathogen. Hospital staff should be cognizant of the potential for harm and take
additional precautions to lower the risk of infection. These precautions include proper
sterilization of medical instruments such as catheters and disinfection of environmental
objects including pillowcases and remotes. Standard EPA-approved disinfectant or
detergent-disinfectant including the use of hypochlorite solutions should be used for
disinfection procedures on environmental objects contaminated with Acinetobacter
baumannii (10, 12, 15). When these precautions fail, microbiologists and
epidemiological staff members can utilize the REP-PCR technique and the VIGI@ct
DiversiLab software to determine the genetic relationships of isolates and therefore
identify outbreak situations earlier (10). After outbreak situations are identified hospital
staff can take appropriate measures, such as further disinfection, disposal of potentially
contaminated reusable equipment, or even temporary ward closures, to limit the
outbreak.
CONCLUSION
Overall, the results of this study and literature review show a need for further
research to be conducted on the virulence factors of Acinetobacter baumanni. There
are conflicting results regarding different factors and whether or not they play a part in
the overall virulence of the organism. For example, studies have shown surface motility
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to be highly variable. No definite link has been determined as the cause for the
variability. Studies should be designed to look at one specific virulence factor using
variable laboratory conditions to determine the role of that specific factor. For example,
to study surface motility of a particular strain, different types and concentrations of
media could be used with the exact same protocol. This will also help determine under
what laboratory conditions it is easiest to observe the motility and create a baseline for
comparing results. Similar studies could be designed for each virulence factor. The
potential for a multi-factorial component to virulence should also be examined
thoroughly. One virulence factor alone may not be the determining factor in whether or
not a particular strain is virulent. Increased pathogenic potential could be linked to the
presence of multiple virulence factors.
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Table 2: Characteristics of bacterial strains used in this study
Isolate MDR or Complex?
Source/Wound
Type
1
2
3*
4
5
6
7
8
9
10
11
12
13
14
15
16
17*
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37

MDR
None
MDR
None
None
MDR
None
None
None
A. calcoaceticus-A. baumannii complex
A. calcoaceticus-A. baumannii complex
MDR
MDR
MDR
MDR
A. calcoaceticus-A. baumannii complex
None
None
None
MDR
None
None
MDR
None
None
MDR
MDR
None
MDR
MDR
MDR A. calcoaceticus-A. baumannii complex
A. calcoaceticus-A. baumannii complex
MDR A. calcoaceticus-A. baumannii complex
A. calcoaceticus-A. baumannii complex
None
MDR
A. calcoaceticus-A. baumannii complex
43

Decubitis Ulcer
Axilla/groin
Axilla/groin
Axilla/groin
Axilla/groin
Axilla/groin
Axilla/groin
Axilla/groin
Axilla/groin
Axilla/groin
Chest Tissue
Axilla/groin
Unknown
Unknown
Unknown
Unknown
Wound
Unknown
Unknown
Blood
Axilla/groin
Axilla/groin
Ischeal Wound
Nares
Nares
Decubitis Ulcer
Decubitis Ulcer
Neck Abscess
Rectal
Butt
Catheter tip
Axilla/groin
Trach
Alveolar lauage
Sputum
Trach aspirate
Axilla/groin

Hospital
Location
3N
A07
1MED
A07J
2MED
2MED
Unknown
Unknown
Unknown
Unknown
7W
2MED
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
7E
A07A
A07A
Unknown
SSE
SSE
S4 (ICU)
1MED
ER
SS3E
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown

Table 2: (continued)
Isolate MDR or Complex?

Source/Wound
Type
38 None
Axilla/groin
39 None
Nares
40 MDR A. calcoaceticus-A. baumannii complex Bronch wash
41 A. calcoaceticus-A. baumannii complex
Axilla/groin
42 MDR
Coccyx wound
43 MDR A. calcoaceticus-A. baumannii complex Axilla/groin
44 MDR
Bone
45 None
Wound
46 None
Wound
47 A. calcoaceticus-A. baumannii complex
Right leg
48 A. calcoaceticus-A. baumannii complex
Axilla/groin
49 None
Axilla/groin
50 None
Axilla/groin
*indicates the strain was unable to be recovered
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Hospital
Location
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
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Hema Resource and Supply, Inc. Defibrinated Horse Blood ordered from Hardy
Diagnostics
Microbiologics Acinteobacter baumannii ATCC 19606
Difco Motility Test Medium
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